January 19, 2021
The Pharma Letter
ADC Bio is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. Read more
ADC Bio is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. Read more
Chairman
Alan Raymond
ADC Therapeutics is the top competitor of ADC Bio. ADC Therapeutics is headquartered in Epalinges, Vaud, and was founded in 2011. ADC Therapeutics competes in the Biotechnology field. ADC Therapeutics generates 58% the revenue of ADC Bio.
January 19, 2021
The Pharma Letter
Today 5:21 AM
Benzinga
January 19, 2021
THE IRISH TIMES
No recent acquisitions found related to ADC Bio
Since ADC Bio was founded in 2010, it has participated in 6 rounds of funding. In total ADC Bio has raised $5.4M. ADC Bio's last funding round was on Dec 2020 for a total of $0
Since ADC Bio was founded in 2010, it has participated in 6 rounds of funding. In total ADC Bio has raised $5.4M. ADC Bio's last funding round was on Dec 2020 for a total of $0
No recent investments found related to ADC Bio